Novel extended quadruplet induction regimens—challenging the need for upfront high-dose therapy in newly diagnosed all-risk multiple myeloma patients
@article{ACTR10704,
author = {Klaus Podar},
title = {Novel extended quadruplet induction regimens—challenging the need for upfront high-dose therapy in newly diagnosed all-risk multiple myeloma patients},
journal = {AME Clinical Trials Review},
volume = {3},
number = {0},
year = {2025},
keywords = {},
abstract = {},
issn = {3005-6152}, url = {https://actr.amegroups.org/article/view/10704}
}